Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Hudson

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Trials|June 4, 2025
Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study)Yazan Haddadin, Vasso Anagnostopoulou, Stephen Bremner, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
The New Zealand Medical Journal|March 13, 2020
Politicians: please work together to minimise the spread of COVID-19David Murdoch, Michael Addidle, Hanna-Sofia Andersson, et al.
The New Zealand Medical Journal|October 25, 2021
Antimicrobial stewardship in human healthcare in Aotearoa New Zealand: urgent call for national leadership and co-ordinated efforts to preserve antimicrobial effectivenessSharon J Gardiner, Eamon J Duffy, Stephen T Chambers, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Trials|June 4, 2025
Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study)Yazan Haddadin, Vasso Anagnostopoulou, Stephen Bremner, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
The New Zealand Medical Journal|March 13, 2020
Politicians: please work together to minimise the spread of COVID-19David Murdoch, Michael Addidle, Hanna-Sofia Andersson, et al.
The New Zealand Medical Journal|October 25, 2021
Antimicrobial stewardship in human healthcare in Aotearoa New Zealand: urgent call for national leadership and co-ordinated efforts to preserve antimicrobial effectivenessSharon J Gardiner, Eamon J Duffy, Stephen T Chambers, et al.
Pageof 8